On the public citation graph

TLRs to cytokines: Mechanistic insights from the imiquimod mouse model of psoriasis

0 signed · 347 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/archderm.134.1.25openalex-snapshot
Self-administered Topical 5% Imiquimod Cream for External Anogenital Warts
inferredcites →https://doi.org/10.1001/archderm.140.12.1490openalex-snapshot
Psoriasis Triggered by Toll-like Receptor 7 Agonist Imiquimod in the Presence of Dermal Plasmacytoid Dendritic Cell Precursors
inferredcites →https://doi.org/10.1002/eji.200535503openalex-snapshot
IL‐22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis
inferredcites →https://doi.org/10.1002/eji.201242569openalex-snapshot
IL ‐17‐producing γδ T cells and innate lymphoid cells
inferredcites →https://doi.org/10.1002/eji.201242598openalex-snapshot
IL ‐23: One cytokine in control of autoimmunity
inferredcites →https://doi.org/10.1016/0166-3542(88)90032-0openalex-snapshot
Modification of immunological responses and clinical disease during topical R-837 treatment of genital HSV-2 infection
inferredcites →https://doi.org/10.1016/j.ajhg.2011.07.022openalex-snapshot
Mutations in IL36RN/IL1F5 Are Associated with the Severe Episodic Inflammatory Skin Disease Known as Generalized Pustular Psoriasis
inferredcites →https://doi.org/10.1016/j.immuni.2011.08.001openalex-snapshot
Pivotal Role of Dermal IL-17-Producing γδ T Cells in Skin Inflammation
inferredcites →https://doi.org/10.1016/j.immuni.2012.11.001openalex-snapshot
Stroma-Derived Interleukin-34 Controls the Development and Maintenance of Langerhans Cells and the Maintenance of Microglia
inferredcites →https://doi.org/10.1016/j.jaad.2006.05.030openalex-snapshot
Imiquimod for the treatment of actinic keratosis: A meta-analysis of randomized controlled trials
inferredcites →https://doi.org/10.1016/j.jaad.2012.08.021openalex-snapshot
Remission of psoriasis after allogeneic, but not autologous, hematopoietic stem-cell transplantation
inferredcites →https://doi.org/10.1016/s0190-9622(98)70243-9openalex-snapshot
Treatment of genital warts with an immune-response modifier (imiquimod)
inferredcites →https://doi.org/10.1016/s0190-9622(99)70261-6openalex-snapshot
Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream
inferredcites →https://doi.org/10.1023/b:appt.0000025805.55340.c3openalex-snapshot
Immune modulation and apoptosis induction: Two sides of the antitumoral activity of imiquimod
inferredcites →https://doi.org/10.1038/jid.2012.512openalex-snapshot
IL-1R1 Signaling Facilitates Munro’s Microabscess Formation in Psoriasiform Imiquimod-Induced Skin Inflammation
inferredcites →https://doi.org/10.1038/jid.2013.477openalex-snapshot
Characterization of Innate Lymphoid Cells in Human Skin and Blood Demonstrates Increase of NKp44+ ILC3 in Psoriasis
inferredcites →https://doi.org/10.1038/nature03963openalex-snapshot
Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins
inferredcites →https://doi.org/10.1038/nature04517openalex-snapshot
Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3
inferredcites →https://doi.org/10.1038/nature10209openalex-snapshot
Genetics and pathogenesis of inflammatory bowel disease
inferredcites →https://doi.org/10.1038/ncomms2566openalex-snapshot
Aldara activates TLR7-independent immune defence
inferredcites →https://doi.org/10.1038/ng.2467openalex-snapshot
Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity
inferredcites →https://doi.org/10.1038/ni.2156openalex-snapshot
IL-17C regulates the innate immune function of epithelial cells in an autocrine manner
inferredcites →https://doi.org/10.1038/ni.2534openalex-snapshot
Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues
inferredcites →https://doi.org/10.1038/ni0602-499openalex-snapshot
Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848
inferredcites →https://doi.org/10.1038/ni758openalex-snapshot
Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway
inferredcites →https://doi.org/10.1038/nri2622openalex-snapshot
Skin immune sentinels in health and disease
inferredcites →https://doi.org/10.1038/sj.jid.5700264openalex-snapshot
Imiquimod for Actinic Keratosis: Systematic Review and Meta-Analysis
inferredcites →https://doi.org/10.1038/sj.jid.5700286openalex-snapshot
The Small Antitumoral Immune Response Modifier Imiquimod Interacts with Adenosine Receptor Signaling in a TLR7- and TLR8-Independent Fashion
inferredcites →https://doi.org/10.1038/sj.jid.5700807openalex-snapshot
Mouse Models of Psoriasis
inferredcites →https://doi.org/10.1038/sj.jid.5701213openalex-snapshot
Psoriasis Vulgaris Lesions Contain Discrete Populations of Th1 and Th17 T Cells
inferredcites →https://doi.org/10.1046/j.1440-0960.2003.00003.xopenalex-snapshot
Short‐course therapy with imiquimod 5% cream for solar keratoses: A randomized controlled trial
inferredcites →https://doi.org/10.1046/j.1523-1747.2000.00833.xopenalex-snapshot
Imiquimod, a Topical Immune Response Modifier, Induces Migration of Langerhans Cells11The authors have declared a conflict of interest.
inferredcites →https://doi.org/10.1055/s-0028-1133030openalex-snapshot
Zur Aetiologie der Psoriasis
inferredcites →https://doi.org/10.1056/nejmra0804595openalex-snapshot
Psoriasis
inferredcites →https://doi.org/10.1073/pnas.1307569110openalex-snapshot
Langerin neg conventional dendritic cells produce IL-23 to drive psoriatic plaque formation in mice
inferredcites →https://doi.org/10.1080/10837459908984222openalex-snapshot
Development of a Topically Active Imiquimod Formulation
inferredcites →https://doi.org/10.1084/jem.20031482openalex-snapshot
Spontaneous Development of Psoriasis in a New Animal Model Shows an Essential Role for Resident T Cells and Tumor Necrosis Factor-α
inferredcites →https://doi.org/10.1084/jem.20050500openalex-snapshot
Plasmacytoid predendritic cells initiate psoriasis through interferon-α production
inferredcites →https://doi.org/10.1093/intimm/dxr110openalex-snapshot
IL-17 and IL-22 enhance skin inflammation by stimulating the secretion of IL-1β by keratinocytes via the ROS-NLRP3-caspase-1 pathway
inferredcites →https://doi.org/10.1093/jnci/djg016openalex-snapshot
Tumor-Selective Induction of Apoptosis and the Small-Molecule Immune Response Modifier Imiquimod
inferredcites →https://doi.org/10.1111/j.1365-2133.1980.tb05690.xopenalex-snapshot
Psoriasis and HLA-Cw6
inferredcites →https://doi.org/10.1111/j.1365-2567.2005.02122.xopenalex-snapshot
Various members of the Toll‐like receptor family contribute to the innate immune response of human epidermal keratinocytes
inferredcites →https://doi.org/10.1126/science.1225152openalex-snapshot
Compartmentalized Control of Skin Immunity by Resident Commensals
inferredcites →https://doi.org/10.1172/jci117308openalex-snapshot
Characterization of dermal dendritic cells in psoriasis. Autostimulation of T lymphocytes and induction of Th1 type cytokines.
inferredcites →https://doi.org/10.1172/jci61034openalex-snapshot
Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells
inferredcites →https://doi.org/10.1172/jci61862openalex-snapshot
Rorγt+ innate lymphocytes and γδ T cells initiate psoriasiform plaque formation in mice
inferredcites →https://doi.org/10.1172/jci63451openalex-snapshot
Psoriasiform dermatitis is driven by IL-36–mediated DC-keratinocyte crosstalk
inferredcites →https://doi.org/10.1182/blood-2006-07-036889openalex-snapshot
Mast cells are crucial for early inflammation, migration of Langerhans cells, and CTL responses following topical application of TLR7 ligand in mice
inferredcites →https://doi.org/10.1189/jlb.0808504openalex-snapshot
TLR7 and TLR8 agonists trigger different signaling pathways for human dendritic cell maturation
inferredcites →https://doi.org/10.1371/journal.pone.0002719openalex-snapshot
Substantial Alterations of the Cutaneous Bacterial Biota in Psoriatic Lesions
inferredcites →https://doi.org/10.1371/journal.pone.0018266openalex-snapshot
Genome-Wide Expression Profiling of Five Mouse Models Identifies Similarities and Differences with Human Psoriasis
inferredcites →https://doi.org/10.4049/jimmunol.0802878openalex-snapshot
Impaired Mast Cell-Driven Immune Responses in Mice Lacking the Transcription Factor NFATc2
inferredcites →https://doi.org/10.4049/jimmunol.0802999openalex-snapshot
Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis
inferredcites →https://doi.org/10.4049/jimmunol.1003162openalex-snapshot
IL-1F5, -F6, -F8, and -F9: A Novel IL-1 Family Signaling System That Is Active in Psoriasis and Promotes Keratinocyte Antimicrobial Peptide Expression
inferredcites →https://doi.org/10.4049/jimmunol.1003244openalex-snapshot
Involvement of Tyrosine Kinase-2 in Both the IL-12/Th1 and IL-23/Th17 Axes In Vivo
inferredcites →https://doi.org/10.4049/jimmunol.1100804openalex-snapshot
Identification of a Novel Proinflammatory Human Skin-Homing Vγ9Vδ2 T Cell Subset with a Potential Role in Psoriasis
inferredcites →https://doi.org/10.4049/jimmunol.1102224openalex-snapshot
IL-22 Is Required for Imiquimod-Induced Psoriasiform Skin Inflammation in Mice
inferredcites →https://doi.org/10.4049/jimmunol.173.5.3051openalex-snapshot
Identification and Characterization of pDC-Like Cells in Normal Mouse Skin and Melanomas Treated with Imiquimod
inferredcites →https://doi.org/10.4049/jimmunol.174.6.3695openalex-snapshot
IL-22 Inhibits Epidermal Differentiation and Induces Proinflammatory Gene Expression and Migration of Human Keratinocytes
inferredcites →https://doi.org/10.4049/jimmunol.180.8.5520openalex-snapshot
A 9-Centimorgan Interval of Chromosome 10 Controls the T Cell-Dependent Psoriasiform Skin Disease and Arthritis in a Murine Psoriasis Model

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.3897/pharmacia.73.e207442zenodo-depositor-declared
Topical febuxostat attenuates imiquimod-induced psoriasiform dermatitis and modulates NFE2L2 (NRF2)/NLRP3 mRNA expression
inferred← citeshttps://doi.org/10.1002/9781119624608.ch10openalex-snapshot
Skin, Hair, and Nails
inferred← citeshttps://doi.org/10.1002/ajoc.202200510openalex-snapshot
Palladium‐Catalyzed Dehydrogenative Synthesis of Imidazoquinolines in Water
inferred← citeshttps://doi.org/10.1002/ange.202203235openalex-snapshot
Chemiluminescent Probes with Long‐Lasting High Brightness for In Vivo Imaging of Neutrophils
inferred← citeshttps://doi.org/10.1002/anie.202203235openalex-snapshot
Chemiluminescent Probes with Long‐Lasting High Brightness for In Vivo Imaging of Neutrophils
inferred← citeshttps://doi.org/10.1002/ardp.202400410openalex-snapshot
Green preparation and evaluation of the anti‐psoriatic activity of vesicular elastic nanocarriers of kojic acid from Aspergillus oryzae N12: Repurposing of a dermo‐cosmetic lead
inferred← citeshttps://doi.org/10.1002/eji.201344133openalex-snapshot
Immunity at the Barriers
inferred← citeshttps://doi.org/10.1002/eji.201445215openalex-snapshot
IMQ‐induced skin inflammation in mice is dependent on IL‐1R1 and MyD88 signaling but independent of the NLRP3 inflammasome
inferred← citeshttps://doi.org/10.1002/eji.201545883openalex-snapshot
Dermal IL‐17‐producing γδ T cells establish long‐lived memory in the skin
inferred← citeshttps://doi.org/10.1002/eji.201546033openalex-snapshot
γδ T cells come to stay: Innate skin memory in the Aldara model
inferred← citeshttps://doi.org/10.1002/eji.202048690openalex-snapshot
TLR7 endogenous ligands remodel glycolytic macrophages and trigger skin‐to‐joint crosstalk in psoriatic arthritis
inferred← citeshttps://doi.org/10.1002/jbio.202500025openalex-snapshot
Label‐Free Multiphoton Microscopy for Diagnosis of Psoriasis
inferred← citeshttps://doi.org/10.1002/jsfa.9097openalex-snapshot
Gold lotion from citrus peel extract ameliorates imiquimod‐induced psoriasis‐like dermatitis in murine
inferred← citeshttps://doi.org/10.1002/path.6162openalex-snapshot
Forward genetics and functional analysis highlight Itga11 as a modulator of murine psoriasiform dermatitis
inferred← citeshttps://doi.org/10.1007/978-1-4939-6786-5_6openalex-snapshot
Surgical Denervation in the Imiquimod-Induced Psoriasiform Mouse Model
inferred← citeshttps://doi.org/10.1007/978-3-319-29785-9_21openalex-snapshot
Immunopathogenesis of Psoriasis
inferred← citeshttps://doi.org/10.1007/978-3-319-29785-9_9openalex-snapshot
Cutaneous Dendritic Cells in Health and Disease
inferred← citeshttps://doi.org/10.1007/978-94-024-1057-0_11openalex-snapshot
Aquaporins in the Skin
inferred← citeshttps://doi.org/10.1007/s00109-023-02349-wopenalex-snapshot
Targeting ACC1 in T cells ameliorates psoriatic skin inflammation
inferred← citeshttps://doi.org/10.1007/s00204-019-02488-5openalex-snapshot
The Toll-like receptor agonist imiquimod is metabolized by aryl hydrocarbon receptor-regulated cytochrome P450 enzymes in human keratinocytes and mouse liver
inferred← citeshttps://doi.org/10.1007/s00210-025-04965-4openalex-snapshot
Andrographolide augments methotrexate’s therapeutic potential in psoriasis: comprehensive in vitro and in vivo evaluation
inferred← citeshttps://doi.org/10.1007/s10735-025-10416-4openalex-snapshot
Vildagliptin topical ointment: an effective treatment for imiquimod-induced psoriasis in mice
inferred← citeshttps://doi.org/10.1007/s10753-024-02127-xopenalex-snapshot
Extending the IMQ Model: Deep Characterization of the Human TLR7 Response for Early Drug Development
inferred← citeshttps://doi.org/10.1007/s10753-026-02471-0openalex-snapshot
Secondary Exposure to IMQ or Irritants Enhances Psoriasiform Recurrence Through Inflammatory Memory
inferred← citeshttps://doi.org/10.1007/s10787-023-01137-9openalex-snapshot
Suprabasin-derived polypeptides: SBSN(50-63) induces inflammatory response via TLR4-mediated mast cell activation
inferred← citeshttps://doi.org/10.1007/s10787-023-01175-3openalex-snapshot
Isostearic acid is an active component of imiquimod formulations used to induce psoriaform disease models
inferred← citeshttps://doi.org/10.1007/s10787-023-01198-wopenalex-snapshot
Diosmin nanocrystal gel alleviates imiquimod-induced psoriasis in rats via modulating TLR7,8/NF-κB/micro RNA-31, AKT/mTOR/P70S6K milieu, and Tregs/Th17 balance
inferred← citeshttps://doi.org/10.1007/s10787-026-02286-3openalex-snapshot
Ruxolitinib phosphate-laden nanoemulgel: amelioration of ex vivo permeation and in vivo therapeutic efficacy for the effective therapeutic management of psoriasis
inferred← citeshttps://doi.org/10.1007/s11302-017-9569-0openalex-snapshot
The P2X7 receptor is not essential for development of imiquimod-induced psoriasis-like inflammation in mice
inferred← citeshttps://doi.org/10.1007/s12010-026-05920-6openalex-snapshot
Enhanced Anti-inflammatory Effects of 18β-Glycyrrhetinic Acid and Hesperetin for the Treatment of Psoriasis: Evidence from LPS-stimulated RAW264.7 Cells and Imiquimod-induced Psoriasis Mouse Model
inferred← citeshttps://doi.org/10.1007/s12026-024-09484-7openalex-snapshot
Immunomodulating effects of the single bacterial strain therapy EDP1815 on innate and adaptive immune challenge responses — a randomized, placebo-controlled clinical trial
inferred← citeshttps://doi.org/10.1007/s12272-016-0806-9openalex-snapshot
Toll-like receptors: promising therapeutic targets for inflammatory diseases
inferred← citeshttps://doi.org/10.1007/s42452-025-08013-xopenalex-snapshot
Greater psoriatic disease progression in male BALB/c mice: implications for preclinical modeling
inferred← citeshttps://doi.org/10.1007/s44411-026-00516-2openalex-snapshot
Topical Dracunculus vulgaris Schott Extract Attenuates Imiquimod-Induced Psoriasis in BALB/c Mice via Clinical and Histopathological Modulation
inferred← citeshttps://doi.org/10.1016/b978-0-323-91296-9.00011-3openalex-snapshot
Essential oils as potential skin antiinflammatory agent and their mechanisms of action
inferred← citeshttps://doi.org/10.1016/b978-0-443-29289-7.00011-4openalex-snapshot
Regulation of drug transporters by inflammation
inferred← citeshttps://doi.org/10.1016/j.actbio.2015.05.036openalex-snapshot
Therapeutic intradermal delivery of tumor necrosis factor-alpha antibodies using tip-loaded dissolvable microneedle arrays
inferred← citeshttps://doi.org/10.1016/j.actbio.2021.07.068openalex-snapshot
Cellular nanovesicles with bioorthogonal targeting enhance photodynamic/photothermal therapy in psoriasis
inferred← citeshttps://doi.org/10.1016/j.ajpath.2016.05.012openalex-snapshot
High-Fat Diet–Induced IL-17A Exacerbates Psoriasiform Dermatitis in a Mouse Model of Steatohepatitis
inferred← citeshttps://doi.org/10.1016/j.ajpath.2018.02.005openalex-snapshot
Imiquimod-Induced Psoriasis-Like Skin Lesions Do Not Accelerate Atherosclerosis in Low-Density Lipoprotein Receptor–Deficient Mice
inferred← citeshttps://doi.org/10.1016/j.arabjc.2024.105612openalex-snapshot
Topical application of berberine ameliorates imiquimod-induced psoriasis-like dermatitis in BALB/c mice via suppressing JAK1/STAT1 signaling pathway
inferred← citeshttps://doi.org/10.1016/j.bbrc.2015.03.001openalex-snapshot
Inhibitory effect of cucurbitacin B on imiquimod-induced skin inflammation
inferred← citeshttps://doi.org/10.1016/j.bcp.2020.113958openalex-snapshot
DC591017, a phosphodiesterase-4 (PDE4) inhibitor with robust anti-inflammation through regulating PKA-CREB signaling
inferred← citeshttps://doi.org/10.1016/j.bioactmat.2023.11.015openalex-snapshot
Biguanide chitosan microneedles with cell-free DNA scavenging ability for psoriasis therapy
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2021.121027openalex-snapshot
Topical cationic hairy particles targeting cell free DNA in dermis enhance treatment of psoriasis
inferred← citeshttps://doi.org/10.1016/j.bioorg.2025.108397openalex-snapshot
Nitazoxanide and Umbelliferone improves Imiquimod-induced psoriasis in Balb/C mice
inferred← citeshttps://doi.org/10.1016/j.bioorg.2026.109959openalex-snapshot
Discovery of 4-((2S,5R)-2-((difluoromethoxy)methyl)-5-(4-(trifluoromethyl)phenyl)piperidin-1-yl)-N-((R)-1-(4-(ethylsulfonyl)phenyl)-2-hydroxyethyl)benzamide as a potent, orally available RORγt inverse agonist
inferred← citeshttps://doi.org/10.1016/j.biopha.2018.12.060openalex-snapshot
Inhibition of spleen tyrosine kinase attenuates psoriasis-like inflammation in mice through blockade of dendritic cell-Th17 inflammation axis
inferred← citeshttps://doi.org/10.1016/j.biopha.2019.109398openalex-snapshot
Cutaneous delivery of [1-(4-chloro-3-nitrobenzenesulfonyl)-1H-indol-3-yl]-methanol, an indole-3-carbinol derivative, mitigates psoriasiform lesion by blocking MAPK/NF-κB/AP-1 activation
inferred← citeshttps://doi.org/10.1016/j.biopha.2019.109747openalex-snapshot
Taxifolin attenuates IMQ-induced murine psoriasis-like dermatitis by regulating T helper cell responses via Notch1 and JAK2/STAT3 signal pathways
inferred← citeshttps://doi.org/10.1016/j.biopha.2021.111950openalex-snapshot
Capsaicin attenuates imiquimod-induced epidermal hyperplasia and cutaneous inflammation in a murine model of psoriasis
inferred← citeshttps://doi.org/10.1016/j.biopha.2024.117431openalex-snapshot
GPR97 depletion aggravates imiquimod-induced psoriasis pathogenesis via amplifying IL-23/IL-17 axis signal pathway
inferred← citeshttps://doi.org/10.1016/j.cbi.2026.111907openalex-snapshot
Imiquimod-induced colitis: A novel ROS/ERK-driven model of intestinal inflammation and barrier dysfunction
inferred← citeshttps://doi.org/10.1016/j.celbio.2026.100593openalex-snapshot
Autolysosomal degradation-inhibitory nanoparticles for enhanced mRNA escape and cytokine therapy
inferred← citeshttps://doi.org/10.1016/j.cellimm.2015.11.006openalex-snapshot
Gradual development of psoriatic skin lesions by constitutive low-level expression of IL-17A
inferred← citeshttps://doi.org/10.1016/j.celrep.2024.113721openalex-snapshot
An axon-T cell feedback loop enhances inflammation and axon degeneration
inferred← citeshttps://doi.org/10.1016/j.drudis.2016.05.008openalex-snapshot
Immune-competent human skin disease models
inferred← citeshttps://doi.org/10.1016/j.ecoenv.2022.114008openalex-snapshot
Effects of ambient PM2.5 on development of psoriasiform inflammation through KRT17-dependent activation of AKT/mTOR/HIF-1α pathway
inferred← citeshttps://doi.org/10.1016/j.ecoenv.2023.115570openalex-snapshot
Transcriptomic profiling of TLR-7-mediated immune-challenge in zebrafish embryos in the presence and absence of glucocorticoid-induced immunosuppression
inferred← citeshttps://doi.org/10.1016/j.ejmech.2020.113004openalex-snapshot
Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment
inferred← citeshttps://doi.org/10.1016/j.ejmech.2024.116269openalex-snapshot
Small-molecule agents for treating skin diseases
inferred← citeshttps://doi.org/10.1016/j.ejphar.2015.03.010openalex-snapshot
Therapeutic and immunomodulatory effects of glucosamine in combination with low-dose cyclosporine A in a murine model of imiquimod-induced psoriasis
inferred← citeshttps://doi.org/10.1016/j.ejphar.2022.175091openalex-snapshot
Therapeutic potential of MCC950, a specific inhibitor of NLRP3 inflammasome
inferred← citeshttps://doi.org/10.1016/j.ejphar.2025.177738openalex-snapshot
The potential effects of ticagrelor and/or sodium butyrate on imiquimod-induced psoriasis in mice model: The role of NLRP3 inflammasome signaling pathway
inferred← citeshttps://doi.org/10.1016/j.fct.2019.04.060openalex-snapshot
Ferulic acid altered IL-17A/IL-17RA interaction and protected against imiquimod-induced psoriasis-like skin injury in mice
inferred← citeshttps://doi.org/10.1016/j.heliyon.2023.e17315openalex-snapshot
Extracts from Seseli mairei Wolff attenuate imiquimod-induced psoriasis-like inflammation by inhibiting Th17 cells
inferred← citeshttps://doi.org/10.1016/j.humimm.2024.110814openalex-snapshot
Cytokines in psoriasis: From pathogenesis to targeted therapy
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2019.118726openalex-snapshot
Fenoldopam mesylate for treating psoriasis: A new indication for an old drug
inferred← citeshttps://doi.org/10.1016/j.imlet.2016.08.012openalex-snapshot
Protective effects of agonistic anti-4-1BB antibody on the development of imiquimod-induced psoriasis-like dermatitis in mice
inferred← citeshttps://doi.org/10.1016/j.intimp.2016.02.001openalex-snapshot
Oral administration of acarbose ameliorates imiquimod-induced psoriasis-like dermatitis in a mouse model
inferred← citeshttps://doi.org/10.1016/j.intimp.2018.09.015openalex-snapshot
Aromatic-turmerone ameliorates imiquimod-induced psoriasis-like inflammation of BALB/c mice
inferred← citeshttps://doi.org/10.1016/j.intimp.2018.12.054openalex-snapshot
Role of Galphaq in pathogenesis of psoriasis, a new mechanism about the immune regulation in psoriasis
inferred← citeshttps://doi.org/10.1016/j.intimp.2020.106258openalex-snapshot
Imiquimod-related dermatitis is mainly mediated by mast cell degranulation via Mas-related G-protein coupled receptor B2
inferred← citeshttps://doi.org/10.1016/j.intimp.2020.106692openalex-snapshot
Complement component 3 prevents imiquimod-induced psoriatic skin inflammation by inhibiting apoptosis in mice
inferred← citeshttps://doi.org/10.1016/j.intimp.2021.107754openalex-snapshot
Galangin ameliorates Imiquimod-Induced psoriasis-like skin inflammation in BALB/c mice via down regulating NF-κB and activation of Nrf2 signaling pathways
inferred← citeshttps://doi.org/10.1016/j.intimp.2023.109945openalex-snapshot
Preclinical study models of psoriasis: State-of-the-art techniques for testing pharmaceutical products in animal and nonanimal models
inferred← citeshttps://doi.org/10.1016/j.jaci.2019.06.019openalex-snapshot
Cutaneous p38 mitogen-activated protein kinase activation triggers psoriatic dermatitis
inferred← citeshttps://doi.org/10.1016/j.jconrel.2019.09.021openalex-snapshot
Selectively targeting tumor-associated macrophages and tumor cells with polymeric micelles for enhanced cancer chemo-immunotherapy
inferred← citeshttps://doi.org/10.1016/j.jconrel.2025.01.037openalex-snapshot
Smart core-shell microneedles for psoriasis therapy: In situ self-assembly of calcium ion-coordinated dexamethasone hydrogel
inferred← citeshttps://doi.org/10.1016/j.jddst.2022.103455openalex-snapshot
Enhancing the anti-psoriatic activity of vitamin D3 employing nanostructured archaeolipid carriers
inferred← citeshttps://doi.org/10.1016/j.jdermsci.2020.05.013openalex-snapshot
Facile skin targeting of a thalidomide analog containing benzyl chloride moiety alleviates experimental psoriasis via the suppression of MAPK/NF-κB/AP-1 phosphorylation in keratinocytes
inferred← citeshttps://doi.org/10.1016/j.jfda.2016.06.003openalex-snapshot
Lactobacillus pentosus GMNL-77 inhibits skin lesions in imiquimod-induced psoriasis-like mice
inferred← citeshttps://doi.org/10.1016/j.jid.2016.05.122openalex-snapshot
The Exonuclease Trex2 Shapes Psoriatic Phenotype
inferred← citeshttps://doi.org/10.1016/j.jid.2016.06.613openalex-snapshot
Effects of Imiquimod on Hair Follicle Stem Cells and Hair Cycle Progression
inferred← citeshttps://doi.org/10.1016/j.jid.2016.07.028openalex-snapshot
Adenosine A2A and A2B Receptors Differentially Modulate Keratinocyte Proliferation: Possible Deregulation in Psoriatic Epidermis
inferred← citeshttps://doi.org/10.1016/j.jid.2016.09.018openalex-snapshot
Effects of Depilation Methods on Imiquimod-Induced Skin Inflammation in Mice
inferred← citeshttps://doi.org/10.1016/j.jid.2017.08.015openalex-snapshot
Lack of Galanin Receptor 3 Alleviates Psoriasis by Altering Vascularization, Immune Cell Infiltration, and Cytokine Expression
inferred← citeshttps://doi.org/10.1016/j.jid.2017.10.029openalex-snapshot
ITK and RLK Inhibitor PRN694 Improves Skin Disease in Two Mouse Models of Psoriasis
inferred← citeshttps://doi.org/10.1016/j.jid.2018.02.040openalex-snapshot
TRPA1 Acts in a Protective Manner in Imiquimod-Induced Psoriasiform Dermatitis in Mice
inferred← citeshttps://doi.org/10.1016/j.jid.2018.03.1509openalex-snapshot
Eosinophils Accelerate Pathogenesis of Psoriasis by Supporting an Inflammatory Milieu that Promotes Neutrophil Infiltration
inferred← citeshttps://doi.org/10.1016/j.jid.2018.10.021openalex-snapshot
Phosphatidylglycerol Inhibits Toll-Like Receptor–Mediated Inflammation by Danger-Associated Molecular Patterns
inferred← citeshttps://doi.org/10.1016/j.jid.2019.06.146openalex-snapshot
Targeting the IL-17 Receptor Using Liposomal Spherical Nucleic Acids as Topical Therapy for Psoriasis
inferred← citeshttps://doi.org/10.1016/j.jid.2021.06.029openalex-snapshot
Inhibition of CtBP-Regulated Proinflammatory Gene Transcription Attenuates Psoriatic Skin Inflammation
inferred← citeshttps://doi.org/10.1016/j.jid.2021.12.036openalex-snapshot
TNFR2 Depletion Reduces Psoriatic Inflammation in Mice by Downregulating Specific Dendritic Cell Populations in Lymph Nodes and Inhibiting IL-23/IL-17 Pathways
inferred← citeshttps://doi.org/10.1016/j.jneuroim.2017.08.001openalex-snapshot
Multiple sclerosis: Skin-induced antigen-specific immune tolerance
inferred← citeshttps://doi.org/10.1016/j.jphotochem.2024.115928openalex-snapshot
Solvent effect on the excited state photophysics of Imiquimod: A DFT/TD-DFT and spectroscopic study
inferred← citeshttps://doi.org/10.1016/j.lfs.2019.117115openalex-snapshot
The potential of Diosgenin in treating psoriasis: Studies from HaCaT keratinocytes and imiquimod-induced murine model
inferred← citeshttps://doi.org/10.1016/j.medmic.2020.100016openalex-snapshot
Role of skin and gut microbiota in the pathogenesis of psoriasis, an inflammatory skin disease
inferred← citeshttps://doi.org/10.1016/j.molmet.2020.101047openalex-snapshot
Psoriatic skin inflammation induces a pre-diabetic phenotype via the endocrine actions of skin secretome
inferred← citeshttps://doi.org/10.1016/j.pharmthera.2022.108198openalex-snapshot
Clinical implications of tristetraprolin (TTP) modulation in the treatment of inflammatory diseases
inferred← citeshttps://doi.org/10.1016/j.phrs.2018.08.014openalex-snapshot
Effect of statins on toll-like receptors: a new insight to pleiotropic effects
inferred← citeshttps://doi.org/10.1016/j.phymed.2024.155783openalex-snapshot
NETs contribute to psoriasiform skin inflammation: A novel therapeutic approach targeting IL-36 cytokines by a small molecule tetrahydroxystilbene glucoside
inferred← citeshttps://doi.org/10.1016/j.pnpbp.2017.12.015openalex-snapshot
Systemic inflammation in asocial BTBR T + tf/J mice predisposes them to increased psoriatic inflammation
inferred← citeshttps://doi.org/10.1016/j.tips.2016.07.002openalex-snapshot
Tristetraprolin as a Therapeutic Target in Inflammatory Disease
inferred← citeshttps://doi.org/10.1016/j.vascn.2021.107054openalex-snapshot
Optimization of psoriasis mouse models
inferred← citeshttps://doi.org/10.1016/j.xphs.2021.08.023openalex-snapshot
Resveratrol-Loaded Vesicular Elastic Nanocarriers Gel in Imiquimod-Induced Psoriasis Treatment: In Vitro and In Vivo Evaluation
inferred← citeshttps://doi.org/10.1016/s2707-3688(23)00015-8openalex-snapshot
Imiquimod liposome gel preparations and their ability to inhibit hypertrophic scars
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.3c00606openalex-snapshot
Discovery and Structural Optimization of Covalent ZAP-70 Kinase Inhibitors against Psoriasis
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.9b00518openalex-snapshot
Structure-Aided Identification and Optimization of Tetrahydro-isoquinolines as Novel PDE4 Inhibitors Leading to Discovery of an Effective Antipsoriasis Agent
inferred← citeshttps://doi.org/10.1021/acs.molpharmaceut.2c00713openalex-snapshot
Novel Synergistic Approach: Tazarotene-Calcipotriol-Loaded-PVA/PVP-Nanofibers Incorporated in Hydrogel Film for Management and Treatment of Psoriasis
inferred← citeshttps://doi.org/10.1021/acsabm.0c00342openalex-snapshot
Rationally Designed Micellar Nanocarriers for the Delivery of Hydrophilic Methotrexate in Psoriasis Treatment
inferred← citeshttps://doi.org/10.1021/acsmedchemlett.0c00063openalex-snapshot
Discovery of BMS-986251: A Clinically Viable, Potent, and Selective RORγt Inverse Agonist
inferred← citeshttps://doi.org/10.1021/acsomega.4c08830openalex-snapshot
Stachys byzantina K. Koch in the Treatment of Skin Inflammation: A Comprehensive Evaluation of Its Therapeutic Properties
inferred← citeshttps://doi.org/10.1038/jid.2015.249openalex-snapshot
Decreased Expression of Caveolin-1 Contributes to the Pathogenesis of Psoriasiform Dermatitis in Mice
inferred← citeshttps://doi.org/10.1038/jid.2015.289openalex-snapshot
Unprocessed Interleukin-36α Regulates Psoriasis-Like Skin Inflammation in Cooperation With Interleukin-1
inferred← citeshttps://doi.org/10.1038/jid.2015.316openalex-snapshot
Circadian Gene Clock Regulates Psoriasis-Like Skin Inflammation in Mice
inferred← citeshttps://doi.org/10.1038/nature13199openalex-snapshot
Nociceptive sensory neurons drive interleukin-23-mediated psoriasiform skin inflammation
inferred← citeshttps://doi.org/10.1038/nature24271openalex-snapshot
Inflammatory memory sensitizes skin epithelial stem cells to tissue damage
inferred← citeshttps://doi.org/10.1038/ncomms11724openalex-snapshot
NFATc1 supports imiquimod-induced skin inflammation by suppressing IL-10 synthesis in B cells
inferred← citeshttps://doi.org/10.1038/ncomms13581openalex-snapshot
Monocyte-derived inflammatory Langerhans cells and dermal dendritic cells mediate psoriasis-like inflammation
inferred← citeshttps://doi.org/10.1038/ncomms8687openalex-snapshot
Adiponectin regulates psoriasiform skin inflammation by suppressing IL-17 production from γδ-T cells
inferred← citeshttps://doi.org/10.1038/nri3646openalex-snapshot
Mechanisms regulating skin immunity and inflammation
inferred← citeshttps://doi.org/10.1038/nri3683openalex-snapshot
The origins and functions of dendritic cells and macrophages in the skin
inferred← citeshttps://doi.org/10.1038/nrn3946openalex-snapshot
Crosstalk between the nociceptive and immune systems in host defence and disease
inferred← citeshttps://doi.org/10.1038/s12276-020-00489-4openalex-snapshot
Pellino1 promotes chronic inflammatory skin disease via keratinocyte hyperproliferation and induction of the T helper 17 response
inferred← citeshttps://doi.org/10.1038/s12276-021-00620-zopenalex-snapshot
2′-Hydroxycinnamaldehyde ameliorates imiquimod-induced psoriasiform inflammation by targeting PKM2-STAT3 signaling in mice
inferred← citeshttps://doi.org/10.1038/s41467-021-24785-3openalex-snapshot
3-hydroxy-L-kynurenamine is an immunomodulatory biogenic amine
inferred← citeshttps://doi.org/10.1038/s41467-024-46130-0openalex-snapshot
A co-assembly platform engaging macrophage scavenger receptor A for lysosome-targeting protein degradation
inferred← citeshttps://doi.org/10.1038/s41590-019-0467-1openalex-snapshot
IL-1R3 blockade broadly attenuates the functions of six members of the IL-1 family, revealing their contribution to models of disease
inferred← citeshttps://doi.org/10.1038/s41591-018-0003-0openalex-snapshot
Differential glucose requirement in skin homeostasis and injury identifies a therapeutic target for psoriasis
inferred← citeshttps://doi.org/10.1038/s41598-018-32668-9openalex-snapshot
A requirement for slc15a4 in imiquimod-induced systemic inflammation and psoriasiform inflammation in mice
inferred← citeshttps://doi.org/10.1038/s41598-020-66490-zopenalex-snapshot
Topical application of endothelin receptor A antagonist attenuates imiquimod-induced psoriasiform skin inflammation
inferred← citeshttps://doi.org/10.1038/s41598-021-90480-4openalex-snapshot
Abnormal composition of microbiota in the gut and skin of imiquimod-treated mice
inferred← citeshttps://doi.org/10.1038/s41598-022-18671-1openalex-snapshot
A cutback in Imiquimod cutaneous toxicity; comparative cutaneous toxicity analysis of Imiquimod nanotransethosomal gel with 5% marketed cream on the BALB/c mice
inferred← citeshttps://doi.org/10.1038/s41598-022-18900-7openalex-snapshot
Effects of splenectomy on skin inflammation and psoriasis-like phenotype of imiquimod-treated mice
inferred← citeshttps://doi.org/10.1038/s42003-020-01308-2openalex-snapshot
Activation of CD8 T cells accelerates anti-PD-1 antibody-induced psoriasis-like dermatitis through IL-6
inferred← citeshttps://doi.org/10.1038/s43856-025-00804-yopenalex-snapshot
Keratinocyte SR-B1 expression and targeting in cytokine-driven skin inflammation
inferred← citeshttps://doi.org/10.1038/srep32575openalex-snapshot
Skin scarification with Plasmodium falciparum peptide vaccine using synthetic TLR agonists as adjuvants elicits malaria sporozoite neutralizing immunity
inferred← citeshttps://doi.org/10.1038/srep38825openalex-snapshot
Overexpression of Glucocorticoid-induced Leucine Zipper (GILZ) increases susceptibility to Imiquimod-induced psoriasis and involves cutaneous activation of TGF-β1
inferred← citeshttps://doi.org/10.1055/s-0041-1726681openalex-snapshot
Differential Psoriatic Effect of Imiquimod on Balb/c and Swiss Mice
inferred← citeshttps://doi.org/10.1073/pnas.1519906113openalex-snapshot
Enhanced stability of tristetraprolin mRNA protects mice against immune-mediated inflammatory pathologies
inferred← citeshttps://doi.org/10.1080/08820139.2025.2449960openalex-snapshot
Innovative Approaches to Psoriasis: Small Molecules Targeting Key Signaling Pathways
inferred← citeshttps://doi.org/10.1080/08923973.2022.2121928openalex-snapshot
Eupatilin inhibits keratinocyte proliferation and ameliorates imiquimod-induced psoriasis-like skin lesions in mice via the p38 MAPK/NF-κB signaling pathway
inferred← citeshttps://doi.org/10.1080/08923973.2025.2470345openalex-snapshot
Birinapant improves imiquimod-induced psoriasis in BALB/c mice
inferred← citeshttps://doi.org/10.1080/14756366.2022.2043852openalex-snapshot
Discovery of novel paeonol-based derivatives against skin inflammation in vitro and in vivo
inferred← citeshttps://doi.org/10.1080/15569527.2021.2003377openalex-snapshot
Curcumin and ustekinumab cotherapy alleviates induced psoriasis in rats through their antioxidant, anti-inflammatory, and antiproliferative effects
inferred← citeshttps://doi.org/10.1080/17425247.2017.1264386openalex-snapshot
Solid lipid nanoparticles and nanostructured lipid carrier-based nanotherapeutics in treatment of psoriasis: a comparative study
inferred← citeshttps://doi.org/10.1080/1744666x.2016.1204232openalex-snapshot
Therapeutic targeting of Toll-like receptors: a review of Toll-like receptors and their signaling pathways in psoriasis
inferred← citeshttps://doi.org/10.1080/17460441.2025.2528959openalex-snapshot
Animal models of psoriasis for novel drug discovery: a literature update
inferred← citeshttps://doi.org/10.1080/21655979.2020.1863015openalex-snapshot
Catalpol ameliorates psoriasis-like phenotypes via SIRT1 mediated suppression of NF-κB and MAPKs signaling pathways
inferred← citeshttps://doi.org/10.1084/jem.20232091openalex-snapshot
A human STAT3 gain-of-function variant drives local Th17 dysregulation and skin inflammation in mice
inferred← citeshttps://doi.org/10.1093/jleuko/qiae254openalex-snapshot
Unveiling the role of resident memory T cells in psoriasis
inferred← citeshttps://doi.org/10.1096/fj.201800354openalex-snapshot
Topical application of anthranilate derivatives ameliorates psoriatic inflammation in a mouse model by inhibiting keratinocyte‐derived chemokine expression and neutrophil infiltration
inferred← citeshttps://doi.org/10.1097/bor.0000000000000358openalex-snapshot
Pathogenesis and immunotherapy in cutaneous psoriasis: what can rheumatologists learn?
inferred← citeshttps://doi.org/10.1097/itx.0000000000000025openalex-snapshot
Signs of chronic itch in the mouse imiquimod model of psoriasiform dermatitis: sex differences and roles of TRPV1 and TRPA1
inferred← citeshttps://doi.org/10.1097/prs.0000000000007617openalex-snapshot
Inflammasome Activation in Pollution-Induced Skin Conditions
inferred← citeshttps://doi.org/10.1101/478529openalex-snapshot
Deciphering the Regulatory Landscape of γδ T Cell Development by Single-Cell RNA-Sequencing
inferred← citeshttps://doi.org/10.1101/cshperspect.a015354openalex-snapshot
Psoriasis
inferred← citeshttps://doi.org/10.1111/1346-8138.13806openalex-snapshot
Critical role of environmental factors in the pathogenesis of psoriasis
inferred← citeshttps://doi.org/10.1111/acer.14400openalex-snapshot
Chronic Alcohol Consumption Exacerbates the Severity of Psoriasiform Dermatitis in Mice
inferred← citeshttps://doi.org/10.1111/bjd.14320openalex-snapshot
Tumour necrosis factor-α plays a significant role in the Aldara-induced skin inflammation in mice
inferred← citeshttps://doi.org/10.1111/bjd.16137openalex-snapshot
Liver fibrosis is associated with cutaneous inflammation in the imiquimod-induced murine model of psoriasiform dermatitis
inferred← citeshttps://doi.org/10.1111/bph.15652openalex-snapshot
Repurposing the anthelmintic praziquantel to treat psoriasis
inferred← citeshttps://doi.org/10.1111/cts.12563openalex-snapshot
Comprehensive, Multimodal Characterization of an Imiquimod‐Induced Human Skin Inflammation Model for Drug Development
inferred← citeshttps://doi.org/10.1111/exd.12944openalex-snapshot
Trem‐1 is not crucial in psoriasiform imiquimod‐induced skin inflammation in mice
inferred← citeshttps://doi.org/10.1111/exd.13131openalex-snapshot
The genetic difference between C57Bl/6J and C57Bl/6N mice significantly impacts Aldara™‐induced psoriasiform dermatitis
inferred← citeshttps://doi.org/10.1111/exd.13149openalex-snapshot
Leptin deficiency in mice counteracts imiquimod (IMQ)‐induced psoriasis‐like skin inflammation while leptin stimulation induces inflammation in human keratinocytes
inferred← citeshttps://doi.org/10.1111/exd.13269openalex-snapshot
TRIM 21 is important in the early phase of inflammation in the imiquimod‐induced psoriasis‐like skin inflammation mouse model
inferred← citeshttps://doi.org/10.1111/exd.13403openalex-snapshot
Imiquimod‐applied Interleukin‐10 deficient mice better reflects severe and persistent psoriasis with systemic inflammatory state
inferred← citeshttps://doi.org/10.1111/exd.14071openalex-snapshot
Role of neuroimmune circuits and pruritus in psoriasis
inferred← citeshttps://doi.org/10.1111/exd.14862openalex-snapshot
The opposite effect of tapinarof between IMQ and IL‐23 induced psoriasis mouse models
inferred← citeshttps://doi.org/10.1111/exd.70245openalex-snapshot
DUSP6 Regulates Skin Inflammation, Parakeratosis and Disease Severity in a Murine Model of Psoriasis
inferred← citeshttps://doi.org/10.1111/imr.12375openalex-snapshot
Nucleic acid‐sensing TLR s and autoimmunity: novel insights from structural and cell biology
inferred← citeshttps://doi.org/10.1111/jcmm.15834openalex-snapshot
The role of Langerhans cells in epidermal homeostasis and pathogenesis of psoriasis
inferred← citeshttps://doi.org/10.1111/jphp.13357openalex-snapshot
Preclinical studies indicate that INFLATIV, an herbal medicine cream containing Pereskia aculeata , presents potential to be marketed as a topical anti-inflammatory agent and as adjuvant in psoriasis therapy
inferred← citeshttps://doi.org/10.1111/phpp.12299openalex-snapshot
Does imiquimod pretreatment optimize 308‐nm excimer laser (UVB) therapy in psoriasis patients?
inferred← citeshttps://doi.org/10.1111/sji.12420openalex-snapshot
Inhibitory Effect of Imiquimod‐Induced Psoriasis‐Like Skin Inflammation in Mice by Histamine H4 Receptor Agonist 4‐Methylhistamine
inferred← citeshttps://doi.org/10.1111/sji.12666openalex-snapshot
UC ‐1V150, a potent TLR 7 agonist capable of activating macrophages and potentiating mA b‐mediated target cell deletion
inferred← citeshttps://doi.org/10.1111/sji.12742openalex-snapshot
Anti‐psoriatic effect of myeloid‐derived suppressor cells on imiquimod‐induced skin inflammation in mice
inferred← citeshttps://doi.org/10.1126/sciadv.abb5274openalex-snapshot
Topical nanoparticles interfering with the DNA-LL37 complex to alleviate psoriatic inflammation in mice and monkeys
inferred← citeshttps://doi.org/10.1126/science.aad9464openalex-snapshot
Designer cells finely tuned for therapy
inferred← citeshttps://doi.org/10.1126/science.aat0963openalex-snapshot
The healing power of painful memories
inferred← citeshttps://doi.org/10.1126/scitranslmed.3007217openalex-snapshot
Integrative Biology Approach Identifies Cytokine Targeting Strategies for Psoriasis
inferred← citeshttps://doi.org/10.1126/scitranslmed.aaf2140openalex-snapshot
First-in-class inhibitor of the T cell receptor for the treatment of autoimmune diseases
inferred← citeshttps://doi.org/10.1146/annurev-immunol-032414-112123openalex-snapshot
Interleukin-22: Immunobiology and Pathology
inferred← citeshttps://doi.org/10.1155/2014/512562openalex-snapshot
Effects of Chinese Formula Jueyin Granules on Psoriasis in an Animal Model
inferred← citeshttps://doi.org/10.1155/2016/6756138openalex-snapshot
Imiquimod Treatment Causes Systemic Disease in Mice Resembling Generalized Pustular Psoriasis in an IL-1 and IL-36 Dependent Manner
inferred← citeshttps://doi.org/10.1155/2017/7807313openalex-snapshot
Natural Modulators of Endosomal Toll-Like Receptor-Mediated Psoriatic Skin Inflammation
inferred← citeshttps://doi.org/10.1155/2018/7931031openalex-snapshot
Antipsoriatic Effects of Wannachawee Recipe on Imiquimod‐Induced Psoriasis‐Like Dermatitis in BALB/c Mice
inferred← citeshttps://doi.org/10.1155/2020/1980456openalex-snapshot
The Protective Effects of 18 β ‐Glycyrrhetinic Acid on Imiquimod‐Induced Psoriasis in Mice via Suppression of mTOR/STAT3 Signaling
inferred← citeshttps://doi.org/10.1155/2020/5980190openalex-snapshot
Immune Regulation of TNFAIP3 in Psoriasis through Its Association with Th1 and Th17 Cell Differentiation and p38 Activation
inferred← citeshttps://doi.org/10.1159/000373955openalex-snapshot
Glycyrrhizin Ameliorates Imiquimod-Induced Psoriasis-like Skin Lesions in BALB/c Mice and Inhibits TNF-a-Induced ICAM-1 Expression via NF-κB/MAPK in HaCaT Cells
inferred← citeshttps://doi.org/10.11603/1811-2471.2025.v.i1.15125openalex-snapshot
ЕКСПЕРИМЕНТАЛЬНЕ ОБҐРУНТУВАННЯ МЕХАНІЗМУ ПРОТИЗАПАЛЬНОЇ ДІЇ ОЧИЩЕНОГО НАФТАЛАНОВОГО МАСЛА
inferred← citeshttps://doi.org/10.11606/d.17.2020.tde-04012021-102752openalex-snapshot
Papel do receptor de succinato 1 (SUCNR1/GPR91) na imunopatologia da psoríase
inferred← citeshttps://doi.org/10.11606/d.42.2016.tde-12082016-103639openalex-snapshot
Avaliação farmacológica de uma nanodispersão contendo GYY4137 (doador de liberação lenta de H2S) na psoríase experimental.
inferred← citeshttps://doi.org/10.11606/d.42.2020.tde-22012020-120448openalex-snapshot
Sistema nanoestruturado para a localização cutânea de compostos doadores de H>sub<2>/sub
inferred← citeshttps://doi.org/10.11606/t.42.2018.tde-08102018-154445openalex-snapshot
Efeitos antipruriginosos do sulfeto de hidrogênio (exógeno e endógeno) sobre o prurido agudo e crônico em pele de camundongos.
inferred← citeshttps://doi.org/10.1172/jci.insight.123390openalex-snapshot
Disrupting the IL-36 and IL-23/IL-17 loop underlies the efficacy of calcipotriol and corticosteroid therapy for psoriasis
inferred← citeshttps://doi.org/10.1172/jci92217openalex-snapshot
CD1b-autoreactive T cells contribute to hyperlipidemia-induced skin inflammation in mice
inferred← citeshttps://doi.org/10.1177/0963689718757482openalex-snapshot
IDO-expressing Fibroblasts Suppress the Development of Imiquimod-induced Psoriasis-like Dermatitis
showing the first 200 of 287 · page through all 287
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.